We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Larimar Therapeutics
LRMR
$398M
| $6.52M | 0.01% |
16,994
+44
| +0.3% | +$19.8K |
|
|
ONCE
977
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.48M | 0.01% |
155,363
-162,014
| -51% | -$8.45M |
|
978
Diamondback Energy
FANG
$55.1B
| $6.44M | 0.01% |
99,702
-692,982
| -87% | -$47.1M |
|
979
Knowles
KN
$3.2B
| $6.43M | 0.01% |
349,087
+3,751
| +1% | +$64.1K |
|
980
CALL
Amazon
AMZN
$2.49T
| $6.4M | 0.01% |
+250,000
| New | +$6.32M |
|
|
SWFT
981
DELISTED
Swift Transportation Company
SWFT
| $6.38M | 0.01% |
424,520
+112,564
| +36% | +$2.37M |
|
|
AVG
982
DELISTED
AVG Technologies N.V.
AVG
| $6.37M | 0.01% |
293,010
-311,315
| -52% | -$7.9M |
|
983
SEI Investments
SEIC
$12.2B
| $6.35M | 0.01% |
131,703
+112,239
| +577% | +$5.71M |
|
984
Carlisle Companies
CSL
$13.8B
| $6.33M | 0.01% |
72,490
+6,881
| +10% | +$688K |
|
|
IHS
985
DELISTED
IHS INC CL-A COM STK
IHS
| $6.33M | 0.01% |
54,567
+44,270
| +430% | +$5.36M |
|
986
Clearwater Paper
CLW
$278M
| $6.33M | 0.01% |
133,894
+121,204
| +955% | +$6.51M |
|
987
Nucor
NUE
$56.4B
| $6.31M | 0.01% |
168,024
+96,079
| +134% | +$4.12M |
|
988
BorgWarner
BWA
$13.1B
| $6.31M | 0.01% |
172,281
-1,163,735
| -87% | -$48.4M |
|
989
Fortune Brands Innovations
FBIN
$6.14B
| $6.3M | 0.01% |
155,397
+127,760
| +462% | +$5.26M |
|
990
QuinStreet
QNST
$893M
| $6.29M | 0.01% |
1,133,523
+1,073,929
| +1,802% | +$6.3M |
|
|
ETP
991
DELISTED
Energy Transfer Partners L.p.
ETP
| $6.29M | 0.01% |
153,100
+60
| +0% | +$2.91K |
|
|
BUFF
992
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $6.28M | 0.01% |
+350,793
| New | +$8.61M |
|
|
BDBD
993
DELISTED
BOULDER BRANDS INC
BDBD
| $6.28M | 0.01% |
766,768
-20,364
| -3% | -$163K |
|
|
TYPE
994
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $6.28M | 0.01% |
287,759
+49,649
| +21% | +$1.14M |
|
995
F5
FFIV
$23B
| $6.27M | 0.01% |
54,119
+53,234
| +6,015% | +$6.52M |
|
996
Rocket Pharmaceuticals
RCKT
$355M
| $6.25M | 0.01% |
+166,273
| New | +$7.63M |
|
997
FirstCash
FCFS
$9.06B
| $6.23M | 0.01% |
155,565
+9,876
| +7% | +$405K |
|
|
GTLS
998
DELISTED
Chart Industries
GTLS
| $6.23M | 0.01% |
324,311
+285,555
| +737% | +$7.53M |
|
999
Astec Industries
ASTE
$1.29B
| $6.23M | 0.01% |
185,841
+80,787
| +77% | +$3.07M |
|
|
CPGX
1000
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| $6.23M | 0.01% |
+340,511
| New | +$8.87M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.